Merck & Co., Inc.

MRK Health Care · Pharmaceuticals & Biotechnology

Latest period 2026-06-30 · 39 filings on record

Quarterly TTM Annual

3Y 5Y 8FY 10Y MAX

FY 2019 → FY 2025 7 YEARS

SHOWING Fiscal years as the company filed them — each point is one closed year from its 10-K, ending on that year's own close. A year with no 10-K on file is assembled from its four quarters and labelled by its ending date instead; a year still open gets no column at all.

Ranked against Health Care · 51 peers

Each grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-30.

Growth 21st pct

▼−6 over range · as of 2025-12-31

Quality 71st pct

▲+52 over range · as of 2025-12-31

Safety 48th pct

▲+15 over range · as of 2025-12-31

OVERVIEWYoY Δ

Latest fiscal year · ending 2025-12-31 · green = improving · click a row to chart it

Revenue $65.0B +1.3% Gross margin 74.8% −1.5pp Operating margin — — Net margin 28.1% +1.4pp CHARTED Net income $18.3B +6.6%

Debt / equity 0.94 +17.0%

EPS (diluted) $7.28 +8.0% EBITDA — —

Filings

Full history 39 match

ALL 10-K 10-Q Q1 Q2 Q3 FY SORT NEWEST ↓

Filings by fiscal year and period
Year	Q1	Q2	Q3	FY
2026	10-Q Q1 2026	10-Q Q2 2026	no filing	no filing
2025	10-Q Q1 2025	10-Q Q2 2025	10-Q Q3 2025	10-K FY 2025
2024	10-Q Q1 2024	10-Q Q2 2024	10-Q Q3 2024	10-K FY 2024
2023	10-Q Q1 2023	10-Q Q2 2023	10-Q Q3 2023	10-K FY 2023
2022	10-Q Q1 2022	10-Q Q2 2022	10-Q Q3 2022	10-K FY 2022
2021	10-Q Q1 2021	10-Q Q2 2021	10-Q Q3 2021	10-K FY 2021
2020	10-Q Q1 2020	10-Q Q2 2020	10-Q Q3 2020	10-K FY 2020
2019	no filing	no filing	10-Q Q3 2019	10-K FY 2019

10-Q Q2 2026 2026-08-07 Pro → 10-Q Q1 2026 2026-05-04 Pro → 10-K FY 2025 2026-02-24 Pro → 10-Q Q3 2025 2025-11-05 Pro → 10-Q Q2 2025 2025-08-05 Pro → 10-Q Q1 2025 2025-05-02 Pro →

All 39 filings

Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans

Trends

Fiscal years as the company filed them

Revenue

Latest$65.0B YoY+1.3% Periods7

Revenue by period
Period	Period end	Revenue
FY 2019	2019-12-31	$39.1B
FY 2020	2020-12-31	$41.5B
FY 2021	2021-12-31	$48.7B
FY 2022	2022-12-31	$59.3B
FY 2023	2023-12-31	$60.1B
FY 2024	2024-12-31	$64.2B
FY 2025	2025-12-31	$65.0B

Net income

Latest$18.3B YoY+6.6% Periods7

Net income by period
Period	Period end	Net income
FY 2019	2019-12-31	$9.8B
FY 2020	2020-12-31	$7.1B
FY 2021	2021-12-31	$13.0B
FY 2022	2022-12-31	$14.5B
FY 2023	2023-12-31	$365.0M
FY 2024	2024-12-31	$17.1B
FY 2025	2025-12-31	$18.3B

Net margin

Latest28.1% YoY+1.4pp Periods7

Net margin by period
Period	Period end	Net margin
FY 2019	2019-12-31	25.2%
FY 2020	2020-12-31	17.0%
FY 2021	2021-12-31	26.8%
FY 2022	2022-12-31	24.5%
FY 2023	2023-12-31	0.6%
FY 2024	2024-12-31	26.7%
FY 2025	2025-12-31	28.1%

ZOOM

FY 2019 FY 2025

Grade history

Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.

Growth 21 Quality 71 Safety 48

Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100

Grade history by period
Period	Period end	Growth	Quality	Safety
FY 2019	2019-12-31	not scored	not scored	not scored
FY 2020	2020-12-31	not scored	not scored	not scored
FY 2021	2021-12-31	not scored	not scored	not scored
FY 2022	2022-12-31	not scored	not scored	not scored
FY 2023	2023-12-31	27	19	33
FY 2024	2024-12-31	73	64	46
FY 2025	2025-12-31	21	71	48